Item 16. FORM 10-K SUMMARY

8K characters. Original on sec.gov · Markdown

Item 16. FORM 10-K SUMMARY

None.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on February 23, 2023.

EQUIFAX INC.
(Registrant)
By:/s/ Mark W. Begor
Mark W. Begor
Chief Executive Officer

We, the undersigned directors and executive officers of Equifax Inc., hereby severally constitute and appoint John W. Gamble, Jr. and James M. Griggs, and each of them singly, our true and lawful attorneys with full power to them and each of them to sign for us, and in our names in the capacities indicated below, any and all amendments to this Annual Report on Form 10-K filed with the SEC, hereby ratifying and confirming our signatures as they may be signed by our said attorneys to any and all amendments to said Annual Report on Form 10-K.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on February 23, 2023.

/s/ Mark W. Begor
Mark W. Begor
Chief Executive Officer
(Principal Executive Officer)
/s/ John W. Gamble, Jr.
John W. Gamble, Jr.
Executive Vice President, Chief Financial Officer and Chief Operations Officer
(Principal Financial Officer)
/s/ James M. Griggs
James M. Griggs
Chief Accounting Officer and Corporate Controller
(Principal Accounting Officer)
/s/ Mark L. Feidler
Mark L. Feidler
Director and Non-Executive Chairman
/s/ Karen L. Fichuck
Karen L. Fichuck
Director
/s/ G. Thomas Hough
G. Thomas Hough
Director
/s/ Robert D. Marcus
Robert D. Marcus
Director
/s/ Scott A. McGregor
Scott A. McGregor
Director
/s/ John A. McKinley
John A. McKinley
Director
/s/ Robert W. Selander
Robert W. Selander
Director
/s/ Melissa D. Smith
Melissa D. Smith
Director
/s/ Audrey Boone Tillman
Audrey Boone Tillman
Director
/s/ Heather H. Wilson
Heather H. Wilson
Director

SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS

2022

Column AColumn BColumn CColumn DColumn E
Additions
DescriptionBalance at Beginning of PeriodCharged to Costs and ExpensesCharged to Other AccountsDeductionsBalance at End of Period
(In millions)
Reserves deducted in the balance sheet from the assets to which they apply:
Trade accounts receivable$13.9$8.5$—$(3.3)$19.1
Deferred income tax asset valuation allowance192.0(15.4)(9.7)18.2185.1
$205.9$(6.9)$(9.7)$14.9$204.2

2021

Column AColumn BColumn CColumn DColumn E
Additions
DescriptionBalance at Beginning of PeriodCharged to Costs and ExpensesCharged to Other AccountsDeductionsBalance at End of Period
(In millions)
Reserves deducted in the balance sheet from the assets to which they apply:
Trade accounts receivable$12.9$0.3$—$0.7$13.9
Deferred income tax asset valuation allowance382.7(12.7)(198.0)20.0192.0
$395.6$(12.4)$(198.0)$20.7$205.9

2020

Column AColumn BColumn CColumn DColumn E
Additions
DescriptionBalance at Beginning of PeriodCharged to Costs and ExpensesCharged to Other AccountsDeductionsBalance at End of Period
(In millions)
Reserves deducted in the balance sheet from the assets to which they apply:
Trade accounts receivable$11.2$6.3$—$(4.6)$12.9
Deferred income tax asset valuation allowance379.8(34.4)10.127.2382.7
$391.0$(28.1)$10.1$22.6$395.6

Previous: Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES